Alpine Immune Sciences, Inc. (ALPN) Ownership

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$64.97
Day's range
$65

Alpine Immune Sciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
DECHENG CAPITAL LLC 05/14/2024 8.32 M $329.72 M   17.43% 12.99%
AVORO CAPITAL ADVISORS LLC 05/15/2024 5.78 M $228.92 M   100.00% 9.02%
BLACKROCK INC. 05/10/2024 3.58 M $141.72 M   16.89% 5.58%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2024 3.13 M $124.11 M   0.00% 4.89%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2024 3.08 M $122.10 M   82.56% 4.81%
STATE STREET CORP 05/15/2024 2.85 M $112.81 M   104.73% 4.44%
VANGUARD GROUP INC 05/10/2024 2.71 M $107.51 M   21.37% 4.24%
CORMORANT ASSET MANAGEMENT, LP 05/15/2024 2.70 M $107.03 M   5.88% 4.22%
ORBIMED ADVISORS LLC 05/15/2024 2.68 M $106.25 M   5.73% 4.19%
LYNX1 CAPITAL MANAGEMENT LP 05/15/2024 2.25 M $89.32 M   -40.92% 3.52%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2024 2.12 M $84.08 M   -33.23% 3.31%
DARWIN GLOBAL MANAGEMENT, LTD. 05/15/2024 1.98 M $78.57 M   100.00% 3.10%
COMMODORE CAPITAL LP 05/15/2024 1.38 M $54.51 M   -14.60% 2.15%
OCTAGON CAPITAL ADVISORS LP 05/15/2024 1.24 M $49.21 M   0.00% 1.94%
AVIDITY PARTNERS MANAGEMENT LP 05/15/2024 1.17 M $46.57 M   100.00% 1.83%
GREAT POINT PARTNERS LLC 05/15/2024 1.13 M $44.73 M   -69.53% 1.76%
FRANKLIN RESOURCES INC 05/13/2024 1.09 M $43.33 M   -10.42% 1.71%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2024 910.60 K $36.10 M   19.13% 1.42%
MORGAN STANLEY 10/17/2024 789.65 K $31.30 M   9.87% 1.23%
TWO SIGMA ADVISERS, LP 05/15/2024 668.78 K $26.51 M   153.25% 1.04%
VIVO CAPITAL, LLC 04/22/2024 520.51 K $20.79 M   -36.47% 0.81%
TWO SIGMA INVESTMENTS, LP 05/15/2024 519.97 K $20.61 M   37.41% 0.81%
NUVEEN ASSET MANAGEMENT, LLC 05/13/2024 513.18 K $20.34 M   294.85% 0.80%
FIRST LIGHT ASSET MANAGEMENT, LLC 05/15/2024 501.24 K $19.87 M   100.00% 0.78%
JANUS HENDERSON GROUP PLC 05/15/2024 450.83 K $17.84 M   -22.70% 0.70%
D. E. SHAW & CO., INC. 05/15/2024 428.56 K $16.99 M   45.01% 0.67%
CANDRIAM S.C.A. 05/06/2024 415.00 K $16.45 M   -11.70% 0.65%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2024 408.54 K $16.19 M   100.00% 0.64%
ARTAL GROUP S.A. 05/17/2024 405.78 K $16.09 M   699.43% 0.63%
BALYASNY ASSET MANAGEMENT L.P. 05/13/2024 373.00 K $14.79 M   100.00% 0.58%
VESTAL POINT CAPITAL, LP 05/14/2024 350.00 K $13.87 M   100.00% 0.55%
NORTHERN TRUST CORP 05/14/2024 341.70 K $13.55 M   15.17% 0.53%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2024 339.14 K $13.44 M   14.02% 0.53%
BANK OF NEW YORK MELLON CORP 04/25/2024 325.94 K $12.92 M   218.45% 0.51%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2024 310.00 K $12.29 M   -56.62% 0.48%
INVESCO LTD. 05/14/2024 272.63 K $10.81 M   12.76% 0.43%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2024 267.23 K $10.59 M   14.32% 0.42%
NAN FUNG GROUP HOLDINGS LTD 05/14/2024 263.94 K $10.46 M   0.00% 0.41%
IKARIAN CAPITAL, LLC 05/17/2024 261.37 K $10.36 M   -46.36% 0.41%
ATIKA CAPITAL MANAGEMENT LLC 05/14/2024 256.00 K $10.15 M   100.00% 0.40%
WOODLINE PARTNERS LP 05/15/2024 254.33 K $10.08 M   -74.57% 0.40%
RENAISSANCE TECHNOLOGIES LLC 05/13/2024 244.98 K $9.71 M   13.06% 0.38%
GOLDMAN SACHS GROUP INC 05/15/2024 240.44 K $9.53 M   21.47% 0.38%
FMR LLC 05/13/2024 238.56 K $9.46 M   0.01% 0.37%
RAFFERTY ASSET MANAGEMENT, LLC 05/13/2024 234.63 K $9.30 M   192.69% 0.37%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2024 230.00 K $9.12 M   100.00% 0.36%
CITIGROUP INC 05/10/2024 207.50 K $8.23 M   479.97% 0.32%
WALLEYE CAPITAL LLC 05/15/2024 206.10 K $8.17 M   -43.68% 0.32%
DEUTSCHE BANK AG\ 06/02/2025 204.48 K $8.11 M   57.92% 0.32%
BANK OF AMERICA CORP /DE/ 05/15/2024 202.41 K $8.02 M   120.58% 0.32%

Alpine Immune Sciences, Inc. institutional Ownership - FAQ's

During the previous two years, 7 institutional investors and hedge funds held shares of Alpine Immune Sciences, Inc.. The most heavily invested institutionals were:

BlackRock Inc.: 0

CREDIT SUISSE AG/: 32,211

Ziegler Capital Management, LLC: 23,982

Point72 Middle East FZE: 7,900

Decheng Capital Management III (Cayman), LLC: 6.71 M

Amalgamated Financial Corp.: 1,891

100.87% of Alpine Immune Sciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 6.77 M shares in the last 24 months. This purchase volume represents approximately $440.12 M in transactions.